Circulating Tumor DNA in Intermediate Risk Rhabdomyosarcoma
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
To be updated
应用场景：
创建时间：
2022-12-23
相关数据集
Chromatin states and transcription factor binding in SIX1 deficient Rhabdomyosarcoma cells. Chromatin states and transcription factor binding in SIX1 deficient Rhabdomyosarcoma cells
Genetic and shRNA-mediated inhibition of SIX1 expression in RMS cells induces myogenic differentiation and impedes RMS tumor growth. To elucidate the mechanism by which SIX1 loss activates a different
NIAID Data Ecosystem90
Curcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-κB Activity
Ionizing radiation (IR) is an essential component of therapy for alveolar rhabdomyosarcoma. Nuclear factor-kappaB (NF-κΒ) transcription factors are upregulated by IR and have been implicated in radior
NIAID Data Ecosystem50
Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biologic Studies (10C0086)
This study (10-C-0086) collected and analyzed tumor and circulating tumor omics of pediatric and young adult patients with relapsed rhabdomyosarcoma who were co-enrolled in and receiving treatment on
NIAID Data Ecosystem20
Data_Sheet_1_Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors.pdf
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma with poor prognosis. RMS frequently show Hedgehog (HH) pathway activity, which is predominantly seen in the embryonal subtype (E
NIAID Data Ecosystem90
CRCQV42Run026-18 - samples
Targeted capture ctDNA Library CRCQV42Run026-18 from patient PBC0001299, plasma baseline repeat sampleEGA dataset EGAD00001010491
NIAID Data Ecosystem40
